Presentation

COST-UTILITY ANALYSIS OF MAGNESIUM SULPHATE REGIMENS (PRITCHARD VERSUS ZUSPAN) IN THE MANAGEMENT OF SEVERE PRE-ECLAMPSIA: EVIDENCE FROM TWO HOSPITALS IN WEST AFRICA OVER A 12-MONTH PERIOD

Mar 18, 2026, 21:38 PM
ECONOMIC IMPACT OF ADDING TALAZOPARIB TO ENZALUTAMIDE IN PATIENTS WITH HRRM MCRPC

Mar 18, 2026, 21:38 PM
EFFICACY OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS IN REAL-WORLD SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Mar 18, 2026, 21:38 PM
COMPARATIVE ANALYSIS OF HEALTHCARE COST REDUCTION ACROSS INTENSIVE SUPPORT MODALITIES IN JAPAN’S SPECIFIC HEALTH GUIDANCE PROGRAM: USING LARGE-SCALE REAL-WORLD DATA OF EMPLOYMENT-BASED HEALTH INSURANCE CLAIMS (WELLNESS STAR DATABASE)

Mar 18, 2026, 21:38 PM
A METHODOLOGICAL COMPARISON OF THREE LANDMARKING APPROACHES FOR TIME-TO-EVENT PREDICTION: PREDICTING DIAGNOSED CANNABIS USE DISORDER AMONG MEDICAL MARIJUANA CARDHOLDERS IN ARKANSAS

Mar 18, 2026, 21:38 PM
COST-EFFECTIVENESS ANALYSIS WITH REAL-WORLD DATA REUSING BRAZILIAN HEALTH SYSTEM DATABASES: A CASE STUDY IN BREAST CANCER

Mar 18, 2026, 21:38 PM
ESTIMATING PRODUCTIVITY LOSS FROM A SOCIETAL PERSPECTIVE: A PRACTICAL FRAMEWORK USING U.S. PUBLIC-USE DATA

Mar 18, 2026, 21:38 PM
ECONOMIC OUTCOMES OF A RATIONALIZED AND INDIVIDUALIZED THERAPEUTIC MODEL FOR COMPLEX RESPIRATORY CONDITIONS: A REAL-WORLD STUDY

Mar 18, 2026, 21:38 PM
ROBOTIC-ASSISTED NIPPLE-SPARING MASTECTOMY WITH THE DA VINCI SURGICAL SYSTEM COMPARED TO OPEN SURGERY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

Mar 18, 2026, 21:38 PM
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES

Mar 18, 2026, 21:38 PM
DETERMINING AN ECONOMICALLY JUSTIFIABLE PRICE FOR TRONTINEMAB IN EARLY ALZHEIMER’S DISEASE

Mar 18, 2026, 21:38 PM
COST-SAVING OUTCOMES FROM THE IDENTIFICATION AND MANAGEMENT OF PHARMACOLOGICAL INEFFICIENCIES IN PATIENTS WITH CHRONIC DISEASES

Mar 18, 2026, 21:38 PM
DISPROPORTIONALITY ANALYSIS AND MULTIMODAL GENETIC ASSESSMENT OF PAPILLEDEMA ASSOCIATED WITH PROTEASOME INHIBITORS

Mar 18, 2026, 21:38 PM
ASSOCIATIONS BETWEEN SOCIAL MEDIA USAGE MOTIVATIONS, DEPENDENCY, AND OFFLINE SOCIAL OUTCOMES

Mar 18, 2026, 21:38 PM
REAL WORLD EVIDENCE FOR LABEL EXPANSION: IDENTIFYING OFF-LABEL USE TRENDS IN THE HOSPITAL SETTING

Mar 18, 2026, 21:38 PM
LABORATORY-BASED MACHINE LEARNING ALGORITHM REDUCES UNCERTAINTY AND ENHANCES DIAGNOSTIC ACCURACY IN PERIPROSTHETIC JOINT INFECTION

Mar 18, 2026, 21:38 PM
UPTAKE OF THE RSVPREF VACCINE DURING PREGNANCY: ASSOCIATIONS WITH SOCIOECONOMIC STATUS, PRENATAL CARE UTILIZATION, AND MATERNAL RISK FACTORS

Mar 18, 2026, 21:38 PM
ASSESSING GENERIC PREFERENCE-BASED MEASURES FOR PROGRESSIVE SUPRANUCLEAR PALSY: A CONCEPT MAPPING APPROACH

Mar 18, 2026, 21:38 PM
FEASIBILITY ASSESSMENT OF INDIRECT TREATMENT COMPARISON BETWEEN OFF-LABEL RITUXIMAB AND NOVEL TREATMENTS IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA

Mar 18, 2026, 21:38 PM
REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH EGFR-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER

Mar 18, 2026, 21:38 PM

1
2
3
4 (current)
5
6
7
8
9
10

Presentation (CTI)

COST-UTILITY ANALYSIS OF MAGNESIUM SULPHATE REGIMENS (PRITCHARD VERSUS ZUSPAN) IN THE MANAGEMENT OF SEVERE PRE-ECLAMPSIA: EVIDENCE FROM TWO HOSPITALS IN WEST AFRICA OVER A 12-MONTH PERIOD

ECONOMIC IMPACT OF ADDING TALAZOPARIB TO ENZALUTAMIDE IN PATIENTS WITH HRRM MCRPC

EFFICACY OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS IN REAL-WORLD SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS

COMPARATIVE ANALYSIS OF HEALTHCARE COST REDUCTION ACROSS INTENSIVE SUPPORT MODALITIES IN JAPAN’S SPECIFIC HEALTH GUIDANCE PROGRAM: USING LARGE-SCALE REAL-WORLD DATA OF EMPLOYMENT-BASED HEALTH INSURANCE CLAIMS (WELLNESS STAR DATABASE)

A METHODOLOGICAL COMPARISON OF THREE LANDMARKING APPROACHES FOR TIME-TO-EVENT PREDICTION: PREDICTING DIAGNOSED CANNABIS USE DISORDER AMONG MEDICAL MARIJUANA CARDHOLDERS IN ARKANSAS

COST-EFFECTIVENESS ANALYSIS WITH REAL-WORLD DATA REUSING BRAZILIAN HEALTH SYSTEM DATABASES: A CASE STUDY IN BREAST CANCER

ESTIMATING PRODUCTIVITY LOSS FROM A SOCIETAL PERSPECTIVE: A PRACTICAL FRAMEWORK USING U.S. PUBLIC-USE DATA

ECONOMIC OUTCOMES OF A RATIONALIZED AND INDIVIDUALIZED THERAPEUTIC MODEL FOR COMPLEX RESPIRATORY CONDITIONS: A REAL-WORLD STUDY

ROBOTIC-ASSISTED NIPPLE-SPARING MASTECTOMY WITH THE DA VINCI SURGICAL SYSTEM COMPARED TO OPEN SURGERY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES

DETERMINING AN ECONOMICALLY JUSTIFIABLE PRICE FOR TRONTINEMAB IN EARLY ALZHEIMER’S DISEASE

COST-SAVING OUTCOMES FROM THE IDENTIFICATION AND MANAGEMENT OF PHARMACOLOGICAL INEFFICIENCIES IN PATIENTS WITH CHRONIC DISEASES

DISPROPORTIONALITY ANALYSIS AND MULTIMODAL GENETIC ASSESSMENT OF PAPILLEDEMA ASSOCIATED WITH PROTEASOME INHIBITORS

ASSOCIATIONS BETWEEN SOCIAL MEDIA USAGE MOTIVATIONS, DEPENDENCY, AND OFFLINE SOCIAL OUTCOMES

REAL WORLD EVIDENCE FOR LABEL EXPANSION: IDENTIFYING OFF-LABEL USE TRENDS IN THE HOSPITAL SETTING

LABORATORY-BASED MACHINE LEARNING ALGORITHM REDUCES UNCERTAINTY AND ENHANCES DIAGNOSTIC ACCURACY IN PERIPROSTHETIC JOINT INFECTION

UPTAKE OF THE RSVPREF VACCINE DURING PREGNANCY: ASSOCIATIONS WITH SOCIOECONOMIC STATUS, PRENATAL CARE UTILIZATION, AND MATERNAL RISK FACTORS

ASSESSING GENERIC PREFERENCE-BASED MEASURES FOR PROGRESSIVE SUPRANUCLEAR PALSY: A CONCEPT MAPPING APPROACH

FEASIBILITY ASSESSMENT OF INDIRECT TREATMENT COMPARISON BETWEEN OFF-LABEL RITUXIMAB AND NOVEL TREATMENTS IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA

REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH EGFR-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date